CJC-1295 (DAC)
A long-acting growth-hormone-releasing hormone analog studied for sustained GH and IGF-1 elevation.
A GH stack studied for visceral fat reduction with enhanced GH release.
In the literature, Tesamorelin + Ipamorelin appears most often in work focused on visceral fat loss, growth hormone and recovery. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Tesamorelin + Ipamorelin is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
A long-acting growth-hormone-releasing hormone analog studied for sustained GH and IGF-1 elevation.
A synergistic GH stack studied for muscle recovery, sleep quality, and body composition.
A shorter-acting GHRH analog studied for pulsatile, more natural GH release patterns.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.